Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries

被引:0
|
作者
Yuichi Ninomiya
Shuichi Hamasaki
Keishi Saihara
Sanemasa Ishida
Tetsuro Kataoka
Masakazu Ogawa
Koji Orihara
Naoya Oketani
Tsuyoshi Fukudome
Hideki Okui
Tomoko Ichiki
Takuro Shinsato
Takuro Kubozono
Etsuko Mizoguchi
Hitoshi Ichiki
Chuwa Tei
机构
[1] Kagoshima University,Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine
来源
Heart and Vessels | 2008年 / 23卷
关键词
Nitrates; Endothelial function; Shear stress; Vasoconstriction;
D O I
暂无
中图分类号
学科分类号
摘要
The comparative long-term antianginal efficacy of long-acting nitrates versus calcium channel antagonists remains unclear. The goal of the present study was to compare the coronary endothelial cell function and coronary artery vasoconstriction between patients with normal or mildly diseased coronary arteries treated with long-acting nitrates or calcium channel antagonists. Forty-two patients suspected to have angina pectoris and with normal or mildly diseased coronary arteries underwent Doppler flow study of the left anterior descending coronary artery. All patients were suspected to have angina pectoris and were receiving either long-acting nitrates (n = 18; Nitrates group) or calcium channel antagonists (n = 24; Ca-antagonists group) for at least 1 year. Vascular reactivity was assessed by intracoronary administration of papaverine, acetylcholine (Ach), and nitroglycerin using a Doppler guidewire. Segments that showed the greatest constrictive response to Ach were used for assessment of vasoconstriction. The percent increase in coronary blood flow (CBF) and coronary artery diameter (CAD) induced by Ach was significantly smaller in the Nitrates group than in the Ca-antagonists group (33% ± 74% vs 83% ± 77%, P < 0.05; −3% ± 16% vs 11% ± 12%, P < 0.01, respectively). The percent diameter reduction in the region of greatest constrictive response to Ach was significantly greater in the Nitrates group than in the Caantagonists group (44% ± 39% vs 15% ± 32%, P < 0.02). Long-term treatment with long-acting nitrates may produce less favorable effects on coronary endothelial function and the constrictive response to Ach when compared with long-acting calcium channel antagonists in patients with normal or mildly diseased coronary arteries.
引用
收藏
页码:83 / 90
页数:7
相关论文
共 47 条
  • [31] Comparison between beta-blockers and calcium channel blockers in patients with atrial fibrillation according to renal function
    Barcia, Jose Antonio Parada
    Roubin, Sergio Raposeiras
    Fernandez, David Gonzalez
    Garcia, Andre Gonzalez
    Otero, Carla Iglesias
    Bermudez, Inmaculada Gonzalez
    Romo, Andres Iniguez
    Abu-Assi, Emad
    CLINICAL CARDIOLOGY, 2024, 47 (05)
  • [32] HEMODYNAMIC-EFFECTS OF A NEW CALCIUM-ANTAGONIST, SR-33557, IN PATIENTS WITH CORONARY-ARTERY DISEASE AND NORMAL LEFT-VENTRICULAR FUNCTION
    SAAL, JP
    LELLOUCHE, D
    HABBAL, R
    SISSMANN, J
    CASTAIGNE, A
    DUBOISRANDE, JL
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (01) : 87 - 91
  • [33] The effect of nimodipine, a centrally active calcium antagonist, on visual function and macular blood flow in patients with normal-tension glaucoma and control subjects
    Piltz, JR
    Bose, S
    Lanchoney, D
    JOURNAL OF GLAUCOMA, 1998, 7 (05) : 336 - 342
  • [34] Relationship Between Epicardial Adipose Tissue and Coronary Vascular Function in Patients with Normal Myocardial Perfusion by 82Rb PET/TC
    Nappi, C.
    Acampa, W.
    Imbriaco, M.
    Gaudieri, V.
    Assante, R.
    Zampella, E.
    De Matteis, G.
    Buongiorno, P.
    Puglia, M.
    Ponsiglione, A.
    Dell'Aversana, S.
    Cuocolo, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S24 - S25
  • [35] Evaluation of the Systolic and Diastolic Right Ventricular Function: A Comparison Between Diabetes, Prediabetes and Normal Patients Without Coronary Artery Disease
    Negahban, Zahra
    Rezaei, Mahdokht
    Daei, Mohammad Mahdi
    Mirzadeh, Monirsadat
    CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (06)
  • [36] Relationship between resistant hypertension and coronary vascular function assessed by 82Rb PET/CT in patients with suspected coronary artery disease and normal myocardial perfusion
    Gaudieri, V.
    Acampa, W.
    Nappi, C.
    Assante, R.
    Mannarino, T.
    Zampella, E.
    Panico, M.
    Genova, A.
    De Simini, G.
    Buongiorno, P.
    Daniele, S.
    Cuocolo, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S24 - S24
  • [37] Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries
    Palloshi, A
    Fragasso, G
    Piatti, P
    Monti, LD
    Setola, E
    Valsecchi, G
    Galluccio, E
    Chierchia, SL
    Margonato, A
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (07): : 933 - 935
  • [38] The effect of phototherapy on neonatal calcium and bilirubin levels: a comparison between patients with low and normal G6PD levels
    Sheikh, Mahboobeh
    Ostadrahimi, Pouya
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2023, 19 (01): : 28 - 31
  • [39] Prospective randomized comparison of effect on coronary endothelial and renal function between febuxostat and benzbromarone in hyperuricemic patients with coronary artery disease: EFEF study
    Nishino, Masami
    Egami, Yasuyuki
    Nakamura, Hitoshi
    Ukita, Kohei
    Kawamura, Akito
    Matsuhiro, Yutaka
    Yasumoto, Koji
    Tsuda, Masaki
    Tanaka, Akihiro
    Okamoto, Naotaka
    Matsunaga-Lee, Yasuharu
    Yano, Masamichi
    Shutta, Ryu
    Tanouchi, Jun
    HEALTH SCIENCE REPORTS, 2022, 5 (02)
  • [40] Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: Comparison with a long-acting calcium channel antagonist, amlodipine
    Ohbayashi, Y
    Tsutamoto, T
    Sakaguchi, T
    Tanaka, T
    Kanamori, T
    Yokohama, T
    Sichiri, G
    Hukai, D
    Okabayashi, T
    Ozawa, T
    Ishii, C
    Tsutsui, T
    Ohno, K
    Ohnishi, M
    Wada, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 : S71 - S74